4th Quarter - Report

BIOMERIEUX for BIOMERIEUX

Firm
Client
Income
—
Expenses
$190,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Discussions related to H.R.8078, Sepsis Harm and Cost Reduction Act Discussions regarding H.R.2369, VALID Act of 2023 (Verifying Accurate Leading-edge IVCT Development Act) Discussions regarding H.R.2940, PASTEUR Act (Pioneering Antimicrobial Subscriptions To End Upsurging Resistance Act of 2023) Discussions related to H.R.2377, SALSA Act (Saving Access to Laboratory Services Act)

LobbyistCovered position, as disclosed
ELIZABETH BREWER —
PAUL HARTMAN —
JOHN RICHTER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2377 (118th), H.R. 2940 (118th), H.R. 2369 (118th), H.R. 8078 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.